Expression of Insulin-Like Growth Factor Binding Protein-5 (IGFBP5) Reverses Cisplatin-Resistance in Esophageal Carcinoma

Genetic Variant Near PLXDC2 Influences the Risk of Primary Open-angle Glaucoma by Increasing Intraocular Pressure in the Japanese Population

(2017) Fumihiko Mabuchi et al.   JOURNAL OF GLAUCOMA

VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma

(2017) Zhen-Chuan Liu et al.   Oncotarget

Anti-cancer Effects of a Novel Quinoline Derivative 83b1 on Human Esophageal Squamous Cell Carcinoma through Down-Regulation of COX-2 mRNA and PGE2

(2017) Ivan Ho Yuen Pun et al.   Cancer Research and Treatment

Which factors are associated with extremely short-term survival after surgery in patients with esophageal squamous cell carcinoma?

(2016) Jingeng Liu et al.   Asia-Pacific Journal of Clinical Oncology

Insulin-Like Growth Factors (IGF) and IGF-Binding Proteins (IGFBP) in the Serum of Patients with Ovarian Tumors

(2016) E. S. Gershtein et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Clinical significance of miR-140-5p and miR-193b expression in patients with breast cancer and relationship to IGFBP5

(2015) Gökçe Güllü et al.   GENETICS AND MOLECULAR BIOLOGY

Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance

(2014) Le Yu et al.   CANCER LETTERS

Assessment of insulin-like growth factor 1 receptor as an oncogene in esophageal squamous cell carcinoma and its potential implication in chemotherapy

(2014) WANG MA et al.   ONCOLOGY REPORTS

A Genome-Wide Association Study on Chronic HBV Infection and Its Clinical Progression in Male Han-Taiwanese

(2014) Su-Wei Chang et al.   PLoS One

Carboxypeptidase E promotes cancer cell survival, but inhibits migration and invasion

(2013) Saravana R.K. Murthy et al.   CANCER LETTERS

IGF-1R Targeting Increases the Antitumor Effects of DNA-Damaging Agents in SCLC Model: An Opportunity to Increase the Efficacy of Standard Therapy

(2013) C. Ferte et al.   MOLECULAR CANCER THERAPEUTICS

OncogeneGAEC1regulatesCAPN10expression which predicts survival in esophageal squamous cell carcinoma

(2013) Dessy Chan   WORLD JOURNAL OF GASTROENTEROLOGY

The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin

(2012) Lei Zhao et al.   TUMOR BIOLOGY

Synthesis of 8-Hydroxyquinoline Derivatives as Novel Antitumor Agents

(2012) Sau Hing Chan et al.   ACS Medicinal Chemistry Letters

Role of Insulin-Like Growth Factor-1 Signaling Pathway in Cisplatin-Resistant Lung Cancer Cells

(2011) Yunguang Sun et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

The subcellular localization of IGFBP5 affects its cell growth and migration functions in breast cancer

(2009) Mustafa Akkiprik et al.   BMC CANCER

Inhibition of the insulin-like growth factor 1 receptor pathway enhances the antitumor effect of cisplatin in human malignant mesothelioma cell lines

(2009) Kiyonori Kai et al.   CANCER LETTERS

Hyperactivation of the Insulin-like Growth Factor Receptor I Signaling Pathway Is an Essential Event for Cisplatin Resistance of Ovarian Cancer Cells

(2009) N. Eckstein et al.   CANCER RESEARCH